New Eptinezumab Trial Results Show Promise for Severe Migraine Treatment The phase IV RESOLUTION trial reveals that eptinezumab significantly reduces monthly migraine days in chronic migraine patients, paving a new treatment path.

New Eptinezumab Trial Results Show Promise for Severe Migraine Treatment #Denmark #Chronic_Migraine #Valby #Eptinezumab #RESOLUTION_Trial

Eptinezumab Shows Significant Efficacy for Severe Migraine Patients in RESOLUTION Trial The phase IV RESOLUTION trial reveals that eptinezumab greatly reduces migraine days in patients with chronic migraine, providing new hope for severe migraine sufferers.

Eptinezumab Shows Significant Efficacy for Severe Migraine Patients in RESOLUTION Trial #Denmark #Valby #Vyepti #Eptinezumab #RESOLUTION_Trial